spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 1 Dec 2010
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of CUBICIN
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2010
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 1 Dec 2010
Theratechnologies Welcomes the Arrival of Its New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2010
Accelerator Corporation Finances Eleventh Startup with Acylin Therapeutics, Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Nov 2010
Seattle Genetics Announces Additions to Commercial Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2010
Cardinal Health Acquires Leading Pharmaceutical Distributor in China
Biopharmaceuticals Distribution
 HSMN NewsFeed - 29 Nov 2010
Accentia Biopharmaceuticals Announces Strategic Agreement with Baxter
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2010
Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Increase in LDL-C and Safety Profile Similar to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2010
Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Nov 2010
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen(R) (Baclofen Injection) for the Treatment of Severe Spasticity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Nov 2010
Hospira Names Francois L. Dubois Senior Vice President of Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Cymbalta(R) Delayed-Release 20, 30 and 60 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Nov 2010
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2010
New Data on H.P. Acthar(R) Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 22 Nov 2010
Interim Results From Independent Study of H.P. Acthar(R) Gel in Patients With Advanced Diabetic Nephropathy Presented at American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Nov 2010
Paclitaxel Poliglumex (OPAXIO(R)) Combined with Temozolomide and Radiotherapy Demonstrates High Response Rates with Encouraging Progression Free Survival in Malignant Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2010
Xanodyne Pharmaceuticals, Inc. To Voluntarily Withdraw Darvon(R) and Darvocet-N(R) Products
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 18 Nov 2010
Cardinal Health To Acquire Kinray for $1.3 Billion
Biopharmaceuticals Distribution Mergers & Acquisitions
 HSMN NewsFeed - 17 Nov 2010
Sutro Biopharma Secures $36.5 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Nov 2010
Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2010
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity for BROMDAY
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2010
Omeros Names Dr. Kenneth Ferguson as Vice President, Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2010
European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Nov 2010
Mortality Data Presented for Patients Treated with Effient(R) Who Underwent Isolated Coronary Artery Bypass Surgery
Biopharmaceuticals Cardiology Surgery
 HSMN NewsFeed - 16 Nov 2010
Spencer Pharmaceutical Discloses Al-Dora Holdings as the Buyout Offering Entity
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2010
GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI
Diagnostics Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 16 Nov 2010
Verastem Secures $16 Million in Series A Financing for Novel Cancer Stem Cell Drugs
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Nov 2010
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Otsuka Prevails in U.S. Abilify(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Nov 2010
FDA Approves Eisai’s Halaven(TM) (Eribulin Mesylate) Injection for Treatment of Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Nov 2010
Christine A. Poon Elected to Regeneron Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2010
Rivaroxaban Significantly Reduces Risk of Stroke in Patients With Atrial Fibrillation With Comparable Safety vs. Warfarin in Pivotal Phase 3 Study
Biopharmaceuticals Cardiology Neurology
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 15 Nov 2010
Cerulean Pharma Inc. Closes $24 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2010
AmerisourceBergen Names Steve Collis President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2010
Vanda Pharmaceuticals Appoints Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2010
Delenex Therapeutics Secures CHF 13.5 Million Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Nov 2010
Arbor Pharmaceuticals Completes $34.8 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Nov 2010
Spencer Pharmaceutical to Provide Material Information on the Unsolicited All-Cash Buyout Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2010
FDA Approves Bionovo's Clinical Development Plan for Menerba
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2010
Forest Laboratories, Inc. Announces Executive Management Promotions and Retirement of Lawrence Olanoff as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2010
Amarin Corporation Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2010
Intellipharmaceutics Appoints New CFO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Nov 2010
Hyperion Therapeutics Elects David W. Gryska to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2010
Semafore Pharmaceuticals Receives FDA Orphan Drug Designation for SF1126 in the Treatment of Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Nov 2010
Aqua Pharmaceuticals Welcomes Skip Williams as Executive Director of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
Aqua Pharmaceuticals Welcomes David Crean as Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2010
Ambit Biosciences Strengthens Board of Directors and Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2010
New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE(R) After Inadequate Response to Enbrel(R) or Humira(R) Demonstrate Marked Clinical Improvement
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2010
New Magnetic Resonance Imaging (MRI) Data Show Efficacy of SIMPONI(R) in Treatment of Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2010
Infinity Augments Executive Leadership Team, Appointing New Chief Medical Officer and New Vice President, Product Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
Lilly to Acquire Avid Radiopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2010
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2010
OctoPlus Appoints Jan Hendrik Egberts as CEO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Nov 2010
Euthymics Bioscience, Inc. Names Biotech Executive Timothy J. Barberich to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Nov 2010
Valeant Pharmaceuticals and Gradient Analytics Settle Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Nov 2010
Study in NEJM Shows Novartis Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2010
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2010
Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2010
Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV (acetaminophen) injection for the Management of Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Nov 2010
Astellas Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President of Agensys, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2010
Ligand Announces Approval for Revolade(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Nov 2010
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2010
Neogenix Oncology(R) Receives FDA Orphan Drug Status for Ensituximab (NPC-1C) for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Nov 2010
Spencer Pharmaceutical Partners With National Pharmaceutical in the Development of Central Nervous System Disease Treatments
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Oct 2010
Novartis Drug Afinitor(R) Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2010
AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2010
NeoPharm, Inc. Announces Merger with Insys Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2010
Idera Pharmaceuticals Appoints Sudhir Agrawal as Chairman of Board of Directors and William S. Reardon as Lead Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2010
Vical Names Igor Bilinsky Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2010
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 28 Oct 2010
Idenix Pharmaceuticals Announces Ronald C. Renaud, Jr. Named President, Chief Executive Officer and Member of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2010
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2010
ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2010
EpiCept Corporation and FDA Agree on Development Plan for Ceplene(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Oct 2010
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2010
Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2010
AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2010
Infinity Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Ltd. Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 25 Oct 2010
Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2010
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Oct 2010
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2010
Dicerna Pharmaceuticals Announces Second Close of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2010
K-V Pharmaceutical Company Announces Establishment of New Generic Marketing Subsidiary and Senior Executive Appointment
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 20 Oct 2010
Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA
 HSMN NewsFeed - 20 Oct 2010
Meda: European Approval for Breakyl
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2010
U.S. Food and Drug Administration Approves BARACLUDE(R) (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2010
Celgene Completes Acquisition of Abraxis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2010
Watson's Generic Version of Lotrel(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Oct 2010
Mylan Receives Approvals for Generic Versions of Hyzaar(R) and Cozaar(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Oct 2010
Aldagen Announces Appointment of Lyle A. Hohnke, Ph.D. as Chief Executive Officer
Regenerative Medicine Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2010
YM Biosciences Appoints Dr. Nick Glover as Chief Executive Officer and Announces Annual Meeting
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2010
Pfizer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2010
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2010
Spectrum Pharmaceuticals Announces Appointment of Brett L. Scott as Senior Vice President and Acting Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Oct 2010
Ipsen's Board of Directors Announces Jean-Luc Bélingard’s Departure and the Appointment of Marc de Garidel as New Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2010
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Oct 2010
Warner Chilcott Announces FDA Approval of Next Generation Actonel
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2010
NovaBay Pharmaceuticals Appoints Gail Maderis, BayBio President and CEO and Former Genzyme Senior Executive, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2010
Phase III Novartis Data Show Potential Benefit of Afinitor(R) Plus Sandostatin(R) LAR Depot in Patients with Advanced Carcinoid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Oct 2010
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Oct 2010
Bristol-Myers Squibb Completes Tender Offer for ZymoGenetics, Inc. with 94.9% of Shares Tendered
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Oct 2010
Onyx Pharmaceuticals Provides Status Update on Carfilzomib
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Data Support Hizentra(R) Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin(R) as First-Line Therapy for Primary Immunodeficiency
Biopharmaceuticals
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!